Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$828,704
+$129,851 QoQ
Shares Held
3,263
+14.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#3,202
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. JNJ ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,490 | $1,347,965 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
3,263 | $828,704 | |
| 4 | ABBV |
AbbVie Inc.
|
2,981 | $750,138 | |
| 5 | AMGN |
Amgen Inc
|
1,376 | $498,277 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,950 | $458,079 | |
| 7 | PFE |
Pfizer Inc
|
13,048 | $314,195 | |
| 8 | AZN |
Astrazeneca PLC
|
967 | $183,362 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $828,704 | 3,263 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $698,853 | 2,859 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $584,012 | 2,822 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $573,689 | 3,094 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $469,553 | 3,074 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $503,490 | 3,036 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $446,297 | 3,086 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $636,409 | 3,927 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $594,725 | 4,069 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $617,890 | 3,906 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $351,730 | 2,125 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $410,905 | 2,651 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $445,334 | 2,521 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $452,670 | 2,771 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $457,975 | 2,580 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $247,413 | 1,396 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $131,039 | 766 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $66,053 | 409 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $67,378 | 409 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $67,219 | 409 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $33,679 | 214 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $49,577 | 333 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,640 | 33 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,327 | 33 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||